- AI, retention and revenue recovery: 5 resources for healthcare leaders this week
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared for Discharge
- Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs
- A Danish Couple’s Maverick African Research Finds Its Moment in RFK Jr.’s Vaccine Policy
- FDA Blocked Melanoma Drug As Confusion Reigned Under Makary
- Journalists Unpack Latest on Vaccines, Vaping, and TrumpRx
- NYC Health + Hospitals taps quality chief for 2 hospitals
- Behavioral healthcare’s next challenge: Defining quality access
- CMS pulls back limits on non-standard ACA plans in final rule
- Cone Health expands with new employee health center
- The behavioral health bottleneck keeping patients stuck in repeat crises
- Lenders to assume control of Affordable Care as part of restructuring deal: 5 notes
- Indiana gets federal OK for hospital assessment, Medicaid payment overhaul
- Kennedy Swaps Vaccine Rhetoric for Story Time but Can’t Quite Change the Subject
- New York closes investigation into former SUNY Downstate CEO: Politico
- Premier Health CEO to retire in 2027
- Can literature enhance patient care? Inside NYU Langone’s decade-old experiment
- Supreme Court allows mail-ordered mifepristone
- Sutter Health, California university to launch new medical school with $175M gift
- Where have all the independent physicians gone?
- Psychiatrist pay falls despite broader physician compensation growth: 5 notes
- MemorialCare names hospital CEO, chief medical officer
- The payer mistake draining ASC revenue
- Pharmaceutical company to pay $13.7M to settle allegations of improper physician payments
- Surgical tech pay by state, adjusted for cost of living | 2026
- Providence partners on AI model for mental health crises
- 10 spine surgeons to know in the East US
- Arizona AG touts behavioral health fraud crackdown progress
- 5 federal government, policy updates for dentists to know
- Supply costs, payer challenges drag CommonSpirit Health to -5.8% operating margin in fiscal Q3
- Are physician-owned hospitals poised for a comeback?
- North Carolina health system plans ASC OR relocation
- 5 DSOs making headlines
- 10 troubling stats on the state of the dental workforce
- FDA Approves AI Sepsis Tool That Detects Infection Hours Earlier Than Doctors
- Texas Children's Hospital agrees to launch nation's first 'detransition clinic' to settle state, DOJ investigation
- NYC Health + Hospitals launches behavioral health workforce program
- Michigan hospital plans outpatient surgery expansion
- 10 best-paying cities for early-career gastroenterologists
- Neuroanesthesia pioneer Dr. Cecil Borel dies at 75
- Tennessee dentist retires after 40+ years of services
- Roche's ctDNA-guided approach in post-surgical bladder cancer pays off with Tecentriq nod
- Docs remain skeptical of insurers' pledge to ease prior auth: AMA survey
- After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
- PCOS Gets a New Name in Landmark Women's Health Shift
- Op-ed: Making America healthy again requires more than a committee
- Eisai's slow push toward blockbuster Leqembi sales gains steam with $900M forecast
- Washington AG alleges Providence failed to accommodate pregnant, nursing employees
- SCOTUS temporarily restores telehealth access to abortion pill mifepristone
- SCOTUS temporarily restores telehealth access to abortion pill mifepristone
- Major Review: Antidepressants Safe in Pregnancy, No Added Risk of Autism or ADHD in Kids
- New Wearable Polygraph Tracks Hidden Stress In Babies, Adults
- How Gun Violence News Coverage Is Harming America's Mental Health
- Health execs persevere in new policy landscape
- AI Chatbots Lure U.S. Teens With Fun, Romance and Hidden Dangers
- License To Deliver: Some Midwives Break The Law To Assist With Home Births
- Kennedy, Balancing MAHA and White House, Says He Won’t Run for President in 2028
- FDA Blocked Melanoma Drug as Confusion Reigned Under Makary
- Minnesota Lawmaker Proposes Using Hospital Tax To Fill Charity Care Gap
- As biologics dominate biopharma pipelines, manufacturing hurdles trip up new launches: report
- BridgeBio Pharma teams with awareness groups to spotlight ATTR-CM’s hidden impact on women
- Adult substance use disorder treatment gaps by state
- Park Dental Partners earns $62.7M in Q1 revenue
- 5 numbers making dentists optimistic
- 5 numbers making dentists nervous
- Class-action lawsuits filed against Delta Dental in 4 states
- New York dentist charged in drug case
- US drug overdose deaths drop for 3rd consecutive year
- Epic grows EHR footprint among small health systems even as overall market sales decline in 2025
- AMA’s recommendations for AI in mental healthcare: 3 things to know
- To gain tariff exemptions, drugmakers must reveal US production plans
- U.S. Overdose Deaths Fell to Pre-Pandemic Levels in 2025
- Intermountain hospital to open behavioral health center
- Bipartisan lawmakers reintroduce bill barring PBMs from owning pharmacies
- Health Tech Weekly Rundown: Headspace app launches on Apple Watch; Visby, RAINN partner on safe access program
- Epic, Oracle and Cleveland Clinic among companies to joining CMS prior authorization initiative
- Court approves sale of CVS' Omnicare unit to GenieRx Holdings
- Too Little or Too Much Sleep Ages Every Organ in Your Body
- Doceree launches Daily Command, an AI platform for brand teams co-built by pharma leaders
- Eli Lilly delivers $50M boost to UNICEF’s pediatric health push
- School Recess Key To Learning, Says The American Academy of Pediatrics
- AstraZeneca scores with Imfinzi in another bladder cancer trial, rivaling Merck's Keytruda
- Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?
- Fierce Pharma Asia—BMS-Hengrui's $15B deal; Takeda’s 4.5K layoffs; Daiichi’s oncology ambition
- New Brain Stimulation Technique Improves Parkinson's Symptoms Without Surgery
- Heart Attack Survivors Have Higher Risk Of Brain Decline
- Naming Emotions Can Help Autistic People Cope With Anxiety, Study Finds
- Trump And Kennedy Seek To Relax Safeguards For AI Healthcare Tools
- Trump Demands Medicaid Data for Deportation. Some States Go a Step Further.
- License To Deliver: Some Midwives Break the Law To Assist With Home Births
- FDA floats possible approach to repurpose approved drugs under new uses
- Sun recalls US chemotherapy batch, citing glass particle contamination concerns
- Bora snaps up MacroGenics’ manufacturing, CDMO operations for up to $127.5M
- Salesforce Ventures, Echo Health Ventures back Optura's $17.5M series A to track AI performance
- CMS to withhold $1.3B in Medicaid funds from California, puts state officials on notice about fraud
- BeOne's Venclexta challenger Beqalzi nets FDA approval as first BCL-2 for mantle cell lymphoma
- FDA Commissioner Marty Makary Resigns After Trump Pressure
- New payer-backed ad campaign pushes for No Surprises Act IDR reform
- Viz.ai launches AI-powered pulmonary care platform
- Docs more burned out, skeptical of AI than nurses, survey report finds
- As Trump arrives in China, Big Pharma CEOs are notably absent
- Remarks at the MFA Legal & Compliance 2026 Conference
- GLP-1 Drugs May Improve Breast Cancer Outcomes
- Chromie Health picks up $2M in pre-seed funding, launches SMS AI-powered nurse staffing agent
- Patient involvement in life-shortening conditions: MND Insights
- NYU Langone Health says it received grand jury subpoena over gender-affirming care
- Merck KGaA looks to M&A to bolster its 'rather slim' pipeline
- Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
- Health systems are exploring AI-powered cardiac risk screening. New CMS reimbursement could unlock a business case for it
- Ted Turner's Brain Disease More Common Than Previously Thought, Review Finds
- Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
- Perimenopausal Women Face Greater Heart Risk, Study Finds
- Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim
- Eating Out Linked To Obesity Risk Worldwide
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- Johnson & Johnson bladder cancer survey reveals toll of surgery, BCG treatment
- US Monitors For Hantavirus As WHO Expects More Cases But 'Not Another COVID'
- Nearly 80% of payers prefer vendor-built AI solutions, survey finds
- University of California, union reach late-night deal to avert system-wide strike
- Millions of Women Suffer in Silence From Treatable Pelvic Organ Prolapse
- What's Fueling The High U.S. Death Rate? It Might Not Be What You Think
- Telemedicine Not Breaking The Bank, Also Not Expanding Patient Access
- After-School Sports An Overall Boon To Children And Teens, Study Shows
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up
- Why Are Older Adults Taking Edibles? Survey Reveals Some Surprises
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
Brownstein Hyatt Farber Schreck (Wikipedia)
Their summary of the proposed federal budget is the best I found on a quick internet search. Please feel free to add others, especially more recent information.
I'll follow with an article on the importance of health policy in this election.
Biden Reveals Health Care Priorities in FY 2025 Budget
BROWNSTEIN CLIENT ALERT, MARCH 11, 2024
<clip>
A more detailed breakdown of the Department of Health and Human Services’ (HHS) budget request can be found here. The FY 2025 budget contains numerous health initiatives and priorities including:
- Reduces Drug and Other Health Care Costs for All Americans.
- Expands the IRA’s inflation rebates and $2,000 out-of-pocket prescription drug cost cap beyond Medicare and into the commercial market.
- Extends the $35 cost-sharing cap for a month’s supply of covered insulin products to the commercial market.
- Limits Medicare Part D cost-sharing for high-value generic drugs to no more than $2 for Medicare beneficiaries.
- Increases the pace of drug price negotiations by bringing more drugs into negotiation sooner after they launch.
- Authorizes HHS to negotiate supplemental drug rebates on behalf of interested states to pool purchasing power.
- Makes permanent the expanded Affordable Care Act (ACA) premium tax credits that were extended in the IRA.
- Provides Medicaid-like coverage to individuals in states that have not adopted Medicaid expansion, paired with financial incentives to ensure states maintain their existing expansions.
- Allows banning “facility fees” for telehealth and certain outpatient services in commercial insurance.
- Funds the continued implementation of the No Surprises Act.
- Honors America’s Commitment to Seniors and Americans in Need.
- Extends solvency of the Medicare Hospital Insurance (HI) trust fund indefinitely by ensuring high-income individuals pay their fair share.
- Proposes limiting the portion of Medicaid and CHIP managed care dollars spent on administration and incentivizing more investment in health care services by establishing a medical loss ratio.
- $150 billion over 10 years to improve and expand Medicaid home and community-based services (HCBS).
- Shifts funding for nursing home surveys from discretionary to mandatory beginning in 2026 and increases funding to cover 100% of statutorily mandated surveys.
- Proposes requiring greater transparency of nursing facility ownership and increasing the inspection of facilities with serious safety deficiencies.
- Invests in the Health and Well-Being of Families and the Next Generation.
- $390 million, a 36% increase above the 2023 enacted level, for the Title X Family Planning program to increase the number of patients served to 3.6 million.
- Transforms Behavioral Health Care.
- $1 billion to advance health information technology adoption and engagement in interoperability for certain behavioral health providers.
- Increases funding for the Children’s Mental Health Initiative by $50 million.
- Expands access to behavioral health services through investments in Certified Community Behavioral Health Clinics and Community Mental Health Centers.
- Doubles funding for the Mental Health Crisis Partnership Program.
- Invests in strengthening the behavioral health workforce, including integration into primary care settings.
- Proposes to extend incentive payment programs for Medicare providers in areas with clinician shortages to a broader set of clinicians, including behavioral health clinicians.
- Expands coverage of mental health benefits and strengthens the network of behavioral health providers in commercial insurance.
- Increases funding for the State Opioid Response grant program.
- Invests in a new technical assistance center to strengthen health providers’ understanding and treatment of substance use and women’s mental health.
- Invests in Medical Innovation, Scientific Breakthroughs and the Treatments of Tomorrow.
- $2 billion increase across the National Cancer Institute, Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and cancer projects at the Advanced Research Projects Agency for Health (ARPA-H).
- Additional mandatory funds for the Indian Health Service (IHS) beginning in 2026.
- Proposes creating a nationwide network of centers of excellence and innovation in women’s health.
- Doubles existing funding for the Office of Research on Women’s Health at the National Institutes of Health (NIH).
- Advances Health Equity.
- $376 million, an increase of $82 million above the 2023 enacted level, to support the ongoing implementation of the White House Blueprint for Addressing the Maternal Health Crisis.
- Expands Medicaid maternal health support services during the pregnancy and postpartum period by incentivizing states to reimburse a broad range of providers, including doulas, community health workers, peer support initiatives and nurse home visiting programs.
- $8 billion in discretionary resources in 2025, a 12% increase over the 2021 enacted level, for clinical services, preventative health, facilities construction, contract support costs and tribal leases at IHS.
- Proposes all IHS resources as mandatory beginning in 2026.
- Reauthorizes and increases funding for the Special Diabetes Program for Indians.
- Invests in direct primary care and mental health care services, expanded infrastructure and assistance for rural hospitals to remain open and provide high-quality services.
- Protects and Strengthens Public Health and Health Infrastructure.
- $2.5 billion in discretionary and mandatory funds over 10 years at CDC to support an evidence-based community violence initiative to address the causes of violence in communities and help reduce health inequities that characterize violence.
- $60 million for gun violence research across CDC and NIH.
- $9.8 billion in discretionary and mandatory funding for the Prevention and Public Health Fund, an increase of $499 million over the 2023 enacted level.
- $20 billion in mandatory funding for HHS public health agencies in support of the administration’s biodefense priorities as outlined in the 2022 National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security.
- $75 million in the Administration for Strategic Preparedness and Response (ASPR) to manufacture more essential medicines, medical countermeasures and critical inputs in the United States.
- $12 million to strengthen FDA’s capacity to identify and address potential disruptions and shortage threats.
- Expands end-to-end supply chain visibility to priority FDA-designated essential medicines and devices to prepare for and mitigate potential shortages.
- Creates a new office to coordinate agency-wide activities on supply chain resilience and shortage mitigation efforts for drugs, biologics, medical devices and critical foods.
- Proposes a national program to significantly expand screening, testing, treatment, prevention and monitoring of hepatitis C infections in the United States.
- Proposes a new mandatory program to guarantee PrEP at no cost for all uninsured and underinsured individuals.
- Proposes a new Vaccines for Adults program to provide uninsured adults with access to routine and outbreak vaccines at no cost.
- Invests in protecting the health care system from cyber threats and includes funding for ASPR to coordinate cybersecurity efforts.
- $800 million to help high-need, low-resourced hospitals cover the upfront costs associated with implementing essential cybersecurity practices.
- $500 million for an incentive program to encourage all hospitals to invest in advanced cybersecurity practices.
- $141 million to continue strengthening HHS’s ability to protect and defend HHS systems and information, including $11 million to expand and enhance HHS’ capacity to protect the privacy and security of health information.
- Invests in HHS’ role in promoting the use of artificial intelligence (AI) in health care and public health while protecting against its risks.
As mentioned above, the president’s budget request starts the congressional budget and appropriations process. The budget presented by the Biden administration provides an aspirational roadmap to what the president would like to be implemented and how much Congress integrates these ideas into their own remains to be seen.
Followers of the MHF Forum and Michigan health policy will recognize many of these funds already leveraging policy in our state.
Joe Grogan has penned an avowedly partisan recapitulation of the ways Medicare funding has been looted to finance non medical programs in recent years:
The Honest Truth About Health Policy
As a frail President Biden walks onto the debate stage this week with the considerable challenge of defending a disastrous record on foreign policy, inflation, and border policies, he is certain to try to use healthcare as an area to score points against President Trump. The campaign is already airing ads on the subject. The media largely ignored or misrepresented Trump’s record on healthcare but there is one area that probably can’t be ignored any longer: Biden’s Medicare policies are hitting seniors hard.As he works to boost support from seniors, Biden has attempted to paint Trump as a threat to Medicare, but the truth is that Biden and the Democrats raided Medicare for green energy subsidies and America’s seniors are paying the price. In 2022, Democrats rammed through the Inflation Reduction Act (IRA) with major changes to Medicare’s prescription drug reimbursement—previously an area of bipartisanship—without a single Republican vote.
President Trump by contrast quietly pursued bipartisan changes, engaging with Senators Grassley and Wyden, Majority Leader McConnell and Speaker Pelosi for negotiations on a bipartisan drug pricing bill to help seniors manage drug costs and preserve the program, but that construct was tossed aside when Democrats took both legislative chambers and the White House and had the chance to implement drug price controls.
Much has been written about how Biden’s drug price setting scheme has led numerous developers to cancel research programs, and more cancellations are around the corner. But what has not gotten enough attention is that in a real feat of policy incompetence, cost savings for seniors are still years away, but seniors are already paying more for drug coverage. Plans requested an average premium increase of 21.5% for 2024 and requests will likely be elevated for 2025 as well. While Democrats included a cap on one factor used to determine beneficiary premiums, the cap does not extend to the premium as a whole. This, coupled with poorly designed changes to Medicare Part D’s structure triggered astronomical premium increases.
Part D instability will grow in 2025 and 2026 as the program’s price fixing provisions kick in and the rebates that keep premiums down disappear. Premiums will need to go up or benefit generosity will need to go down. Some plans may simply stop offering coverage in certain areas next year.
Why would Democrats destabilize the program and impose higher costs on seniors? A generous explanation might be that they didn’t think that this many drug development programs would get cancelled and they didn’t understand that the changes they were making to Part D’s structure would be catastrophic. But a more ideological explanation, and I think a more accurate one, is that Democrats just got greedy, which is ironic since this is their standard attack line against drug companies.
When President Trump proposed restructuring Part D to help seniors, all of the savings in drugs costs accrued to seniors and stayed in the Medicare program. But Democrats needed to loot Part D to pay for the green energy subsidies of the IRA.
Put another way, Biden cut benefits from people with a median income of $36,000 per year to subsidize cars purchased by individuals who earn five times as much. This $240 billion raid on Medicare would be shocking if they hadn’t done it before; Democrats cut $450 billion to $716 billion from Medicare to fund the Affordable Care Act.
When Republicans had both legislative houses and the White House under President Trump, we cut taxes. When Democrats had both houses under Obama and Biden, they raided Medicare to create new programs.
So, when Biden says Medicare won’t be cut on his watch, people should know he already did. Under Donald Trump; benefits were made more generous, particularly for Medicare Advantage enrollees, who Trump allowed to better manage their chronic conditions with enhanced benefits, such as home modifications to address disability. Ironically, the Biden Administration has spent the last three years squeezing Medicare Advantage and costing seniors more money. All the while, they have demonized for-profit companies in health care as they waged war against them.
For the first time in history Thursday night’s debate will feature two candidates who have both held the office defending their records, attacking the other’s. Biden’s team is hoping healthcare might provide a rare window to go on offense, but their actions while in office betray them. And by any objective measure, Trump’s record protecting Medicare is far better than the Biden record of looting it.
During the ACA/Obamacare debates, "Healthcare is 1/6 of the economy" became common knowledge.
Yes. They are connected.
In this timely debate prep, NBC refreshes our frame of reference.
Health care just as important as economy. What experts want Biden and Trump to address.
About half of U.S. adults say it is difficult to pay for their medical care. June 26, 2024, 11:03 AM EDTWhen President Joe Biden and former President Donald Trump face off Thursday during the first general election debate, health policy experts say tackling the exorbitant cost of health care is as much a top issue for voters as the U.S. economy.
Health care costs in the United States continue to rise — and Americans increasingly say they are unable to afford the care they need.
There is no issue in health care even remotely close to voter frustration over the high prices patients have to pay for medical care, said Drew Altman, president and CEO of KFF, a nonprofit group that researches health policy issues.
“People tend to think about health care as separate from the economy,” he said. “But when you talk to voters, it’s not separate at all in their heads. Health care is a dimension of their pocketbook economic concerns.”
National health care spending is projected to have increased 7.5% in 2023 to almost $4.8 trillion, faster than the projected growth of the overall economy, according to the Centers for Medicare and Medicaid Services.
The estimated health care spending per person — the average amount spent on health care services for each individual — reached $14,423 in 2023, up from $13,493 in 2022 and $13,012 in 2021.
The rising cost is hitting Americans’ wallets. About half of U.S. adults say it is difficult to afford their health care costs, according to a recent poll from KFF. About 1 in 4 say they — or a family member — had problems paying for health care in the past year.
That often means people will have to skip or delay the care that they need, said Dr. Adam Gaffney, a critical care physician at the Cambridge Health Alliance, who was not involved in the polling. A family member may try to provide financial aid, he added, but attempts to help another can sometimes aggravate problems for the entire family — most notably with medical debt.
"For American households, health care costs are one of the most important economic issues," he said. “What we spend on health care is going to be one of the biggest line items for a lot of families, particularly families with children or with elderly people with chronic diseases.”
No sweeping reform
Although Trump has revived threats to dismantle the Affordable Care Act, also known as Obamacare, major health care reform is unlikely to be a central issue during the debate, Altman said.
Biden is likely to tout the Inflation Reduction Act, which he signed into law in 2022.
Among the provisions is allowing Medicare, for the first time, to directly negotiate drug prices with pharmaceutical companies. Earlier this year, the government began negotiating prices on the 10 costliest prescription drugs covered by Medicare, which included heart medications and diabetes drugs. The government is expected to publish the new negotiated prices by Sept. 1.
Aside from Obamacare and abortion, Trump has provided little detail on what health care policy would look like in a potential second term. He made addressing the high cost of prescription drugs a tentpole of his previous term, including a push to allow states to import drugs from Canada and a rule that would tie prices for certain drugs to prices paid by countries overseas.
The greatest challenge for both Biden and Trump will be pitching health care cost policies that both sides of Congress can get behind, said Robin Feldman, a professor of law and director of the Center for Innovation at UC Law San Francisco.
“Notions of unity and compromise seem to be a distant memory in Congress, as they are in the nation,” she said.
”The idea of a big major sweeping reform has felt unlikely in recent years,” Gaffney said.
Breakthrough reforms remain challenging — but important.
“This distinction between health care as an issue and the economy as an issue at this point drives me crazy, because for real people, there is no distinction,” Altman said. “It’s one of their biggest economic concerns.”
Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















